Various genetic alterations in WHO grade IV glioblastoma have been assessed, including IDH gene mutations and mutations in the promoter region of the TERT gene [10,11]. TERTp mutations have been identified in a subpopulation of GBM and were revealed to be significantly associated with poor clinical prognosis [12,13]. The gene discussed is TERT; the disease is glioblastoma.